Infrared analysis of bones in magnesium-deficient rats treated with vitamin K2

被引:6
作者
Kobayashi, Masatoshi [1 ]
Hara, Kuniko [1 ]
Akiyama, Yasuhiro [1 ]
机构
[1] Eisai & Co Ltd, Appl Drug Res Dept, Clin Res Ctr, Bunkyo Ku, Tokyo 1128088, Japan
关键词
vitamin K-2; mineral/matrix ratio; FTIRI; bone quality; magnesium;
D O I
10.1007/s00774-006-0722-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this study, we compared the effects of vitamin K-2 menatetrenone on bone mechanical properties in rats fed a low-magnesium (Mg) diet. In addition, the mechanism of bone quality was examined using Fourier transform infrared imaging (FTIRI). Thirty 4-week-old male Wistar rats were divided into three groups: intact, low-Mg-control, and low-Mg-MK-4 groups. Rats in the low-Mg groups were given a diet containing 6 mg/100 g Mg (intact, 90 mg/100 g). After an 8-week-treatment, the cortical bone mineral content (CtBMC), outer perimeter, and endo perimeter of the femoral diaphysis in the low-Mg-control group were significantly higher, while the maximum load (ML) and elastic modulus (EM) were 81% and 50% of those in the intact group, respectively (respectively, P < 0.05). In the low-Mg-MK-4 group, ML and EM were significantly higher than in the low-Mg-control group (P < 0.05), with no differences in CtBMC. The mineral/matrix ratios for the periosteal and central regions in the low-Mg-control group were 162% and 120% of those in the intact group (both, P < 0.05), respectively. MK-4 significantly inhibited these increases (P < 0.05). We found that the mineral/matrix ratios for the periosteal region of the femoral diaphysis were negatively correlated with EM, suggesting that an increase in the mineral/matrix ratio may be involved in the reduction of EM and that MK-4 may improve EM by improving the mineral/matrix ratio.
引用
收藏
页码:12 / 18
页数:7
相关论文
共 32 条
  • [1] Methodological considerations in measurement of bone mineral content
    Boivin, G
    Meunier, PJ
    [J]. OSTEOPOROSIS INTERNATIONAL, 2003, 14 (Suppl 5) : S22 - S27
  • [2] Bone mineral crystal size
    Boskey, A
    [J]. OSTEOPOROSIS INTERNATIONAL, 2003, 14 (Suppl 5) : S16 - S20
  • [3] Infrared analysis of the mineral and matrix in bones of osteonectin-null mice and their wildtype controls
    Boskey, AL
    Moore, DJ
    Amling, M
    Canalis, E
    Delany, AM
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (06) : 1005 - 1011
  • [4] Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin
    Boskey, AL
    Gadaleta, S
    Gundberg, C
    Doty, SB
    Ducy, P
    Karsenty, G
    [J]. BONE, 1998, 23 (03) : 187 - 196
  • [5] Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone
    Boskey, AL
    Spevak, L
    Paschalis, E
    Doty, SB
    McKee, MD
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2002, 71 (02) : 145 - 154
  • [6] Microdamage and bone strength
    Burr, D
    [J]. OSTEOPOROSIS INTERNATIONAL, 2003, 14 (Suppl 5) : S67 - S72
  • [7] Glucocorticoid-induced osteoporosis
    Clowes, JA
    Peel, N
    Eastell, R
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2001, 13 (04) : 326 - 332
  • [8] The effect of moderately and severely restricted dietary magnesium intakes on bone composition and bone metabolism in the rat
    Creedon, A
    Flynn, A
    Cashman, K
    [J]. BRITISH JOURNAL OF NUTRITION, 1999, 82 (01) : 63 - 71
  • [10] Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene -: Results from a 3-year randomized clinical trial
    Ettinger, B
    Black, DM
    Mitlak, BH
    Knickerbocker, RK
    Nickelsen, T
    Genant, HK
    Christiansen, C
    Delmas, PD
    Zanchetta, JR
    Stakkestad, J
    Glüer, CC
    Krueger, K
    Cohen, FJ
    Eckert, S
    Ensrud, KE
    Avioli, LV
    Lips, P
    Cummings, SR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07): : 637 - 645